Showing results (191-200 of 343) with videos related to
Sort By:
Pageof 35
Acta Physiologica (Oxford, England)|October 5, 2012
Autonomic nervous control of the urinary bladderP Ochodnicky, B Uvelius, K-E Andersson, et al.British Journal of Clinical Pharmacology|July 1, 1991
Does treatment with beta-adrenoceptor antagonists in vivo alter human adenylate cyclase responsiveness in vitro?M C Michel, M Klüppel, T Philipp, et al.Molecular Pharmacology|December 1, 1993
Selective irreversible binding of chloroethylclonidine at alpha 1- and alpha 2-adrenoceptor subtypesM C Michel, J Kerker, T A Branchek, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 1993
Alpha 1A and alpha 1B-adrenoceptors enhance inositol phosphate generation in rat renal cortexM C Michel, R Büscher, T Philipp, et al.Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1988
Beta-adrenoceptor changes in hypertension: cause or consequence of the elevation in blood pressure?R Kanczik, M Khamssi, M C Michel, et al.European Urology|June 27, 1998
A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testingC de Mey, M C Michel, J McEwen, et al.BJOG : an International Journal of Obstetrics and Gynaecology|March 15, 2006
Safety and tolerability of duloxetine in women with stress urinary incontinenceM Oelke, J-P W R Roovers, M C MichelJournal of Cardiovascular Pharmacology|July 1, 1993
Norepinephrine and neuropeptide Y increase intracellular Ca2+ in cultured porcine aortic smooth muscle cellsW Erdbrügger, P Vischer, H J Bauch, et al.Journal of Human Hypertension|December 15, 2010
Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study)A Januszewicz, E Ritz, G Viberti, et al.International Journal of Clinical Practice|May 27, 2010
Do gender, age or lifestyle factors affect responses to antimuscarinic treatment in overactive bladder patients?T Schneider, D Marschall-Kehrel, J U Hanisch, et al.Pageof 35